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ABSTRACT: Novel variants of OXA-48-type enzymes with the ability to
hydrolyze oxyimino-cephalosporins and carbapenems are increasingly
reported. Since its first report in 2011, OXA-163 is now extensively spread
throughout Argentina, and several variants like OXA-247 have emerged. Here,
we characterized a new blaOXA‑48‑like variant, OXA-438, and we performed a
comparative kinetic analysis with the local variants OXA-247 and OXA-163
and the internationally disseminated OXA-48. blaOXA‑163, blaOXA‑247, and
blaOXA‑438 were located in a 70 kb IncN2 conjugative plasmid. OXA-438
presented mutations in the vicinity of conserved KTG (214−216), with a 2-aa
deletion (R220-I221) and a D224E shift (as in OXA-163) compared to OXA-
48. Despite Kpn163 (OXA-163), Kpn247 (OXA-247) and Eco438 (OXA-
438) were resistant to meropenem and ertapenem, and the transconjugants
(TC) remained susceptible (however, the carbapenems minimum inhibitory
concentrations were ≥3 times 2-fold dilutions higher than the acceptor strain). TC163 and Eco48 were resistant to oxyimino-
cephalosporins, unlike TC247 and TC438. kcat/Km values for cefotaxime in OXA-163 were slightly higher than the rest of the
variants that were accompanied by a lower Km for carbapenems. For OXA-163, OXA-247, and OXA-438, the addition of NaHCO3
improved kcat values for both cefotaxime and ceftazidime; carbapenems kcat/Km values were higher than for oxyimino-cephalosporins.
Mutations occurring near the conserved KTG in OXA-247 and OXA-438 are probably responsible for the improved carbapenems
hydrolysis and decreased inactivation of oxyimino-cephalosporins compared to OXA-163. Dichroism results suggest that deletions at
the β5−β6 loop seem to impact the structural stability of OXA-48 variants. Finally, additional mechanisms are probably involved in
the resistance pattern observed in the clinical isolates.
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Class D or OXA-type enzymes are represented bymore than800 diverse enzymes according to the National Center for
Biotechnology Information (NCBI) database (https://www.
ncbi.nlm.nih.gov/pathogens/beta-lactamase-data-resources/)
or the β-Lactamase Database (BLDB; http://bldb.eu/BLDB.
php?prot=D),1 respectively. This heterogeneous group com-
prises chromosome- and plasmid-encoded enzymes, with some
members possessing <20% sequence identity.2−4 Carbapenem-
hydrolyzing class D β-lactamases (CHDL) belong to a subgroup
that is widespread and are among the main causes of
carbapenem resistance within A. baumannii and Enterobacter-
ales.5
OXA-48 was the first described enzyme from this subgroup
and possesses a high catalytic efficiency for imipenem as
compared to other close relatives, but low activity for oxyimino-
cephalosporins with undetectable activity for ceftazidime.4 Since
the first description of OXA-48, an increasing number of allelic
variants have been described.6−8 These OXA-48-like enzymes
differ from OXA-48 by a few amino-acid substitutions and
deletions.9 Among them, OXA-163 has been only detected in
Enterobacterales from Argentina and Egypt.5 As this variant has
reduced ability to hydrolyze carbapenems but regains activity
toward ceftazidime compared to OXA-48,4,10 its inclusion as a
CHDL can be argued. This behavior has been attributed to a
single Ser220Asp substitution and a four amino-acid deletion
(222-ArgIleGluPro-225) compared to OXA-48 (according to
DBL numbering).11,12 The Ser220Asp substitution is located at
the C-terminal segment of the β5 strand, and the four amino-
acid deletion is in the loop region between the β5 and β6
strands.4 The β5 strand forms one side of the active-site cavity
and contains the conservedmotif K(S/T)G (residues 216−218)
typical for class D β-lactamases (DBLs), and the loop between
β5−β6 strands has been suggested to be important for the ability
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of an OXA-variant to hydrolyze carbapenems; therefore, the
deletion by itself may impact carbapenem hydrolysis.10,13
Recently, novel variants of the OXA-48-like enzymes
(blaOXA‑247 and blaOXA‑438) with the ability to hydrolyze
oxyimino-cephalosporins and carbapenems emerged in Argen-
tina.14 The blaOXA‑438 variant was detected to form an E. coli
isolated from the urine of a pediatric patient suffering fromB-cell
acute lymphoblastic leukemia, which was phenotypically
resistant to carbapenems and susceptible to oxyimino-
cephalosporins. The aim of this work was to characterize this
new variant and to comparatively evaluate the hydrolytic
behavior of OXA-247 and OXA-438.
■ RESULTS AND DISCUSSION
Epidemiological Data and β-Lactamase PCR Results.
Escherichia coli M17224 (ECO438) was isolated in 2014 from
the urine of a pediatric patient suffering from B-cell acute
lymphoblastic leukemia, with a history of multiple hospital-
izations and antimicrobial treatments due to recurrent E. coli
infections. ECO438 was phenotypically resistant to carbape-
nems, but all the biochemical and colorimetric hydrolytic tests
done to confirm carbapenemase activity gave negative results as
well as the ESBL screening, despite an immunochromatographic
test giving a positive signal for OXA-163.15
Polymerase chain reactions (PCRs) were negative for blaKPC,
blaAmpC, and blaOXA‑1 but positive for blaOXA‑48‑like. The new allele
was assigned as blaOXA‑438 by NCBI (https://www.ncbi.nlm.nih.
gov/pathogens/submit-beta-lactamase/). The epidemiological
Table 1. Minimum Inhibitory Concentrations (μg/mL) of Clinical Strains and E. coli Transconjugants Producing OXA-48
Variants
clinical isolates transconjugants acceptor
antibiotics E. coli ECO438 K. pneumonia KPN163 K. pneumonia KPN247 E. coli TC438 E. coli TC163 E. coli TC247 E. coli J53
ampicillin 1024 >1024 >1024 1024 1024 >1024 ≤4
cephalothin 256 >1024 256 64 256 32 16
cefotaxime 0.5 128 1 0.5 16 0.125 0.03
ceftazidime 2 256 32 2 64 4 0.125
imipenem 8 1 8 0.5 0.125 0.5 0.125
meropenem 2 8 8 0.125 0.06 0.125 0.03
ertapenem 16 >32 >32 0.06 1 0.03 0.004
Figure 1. Sequence analysis of OXA-48 variants. Multialignment of amino acid sequences of novel OXA-438 and OXA-247 and other OXA-48
variants, using the standard numbering scheme for OXA-48. The location of α-helices and β-sheets is indicated in the upper side (taken from PDB
3HBR) and relative solvent accessibility in the bottom (blue, highly accessible; cyan, poorly accessible; white, hidden or nonaccessible). Amino acid
motifs that are well conserved among class D β-lactamases are indicated by green (active site conserved motifs) and orange (other conserved motifs)
boxes. The β5−β6 region containing the mutations in OXA-48 variants is indicated by a blue box. The figure was prepared using Espript (http://
espript.ibcp.fr/ESPript/ESPript/).
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and phenotypic data of Klebsiella pneumoniae M11969
(KPN163) and K. pneumoniae M13056 (KPN247) were
described in a previous work.14
Susceptibility Profiles.Minimum inhibitory concentration
(MIC) results revealed that the isolate ECO438 harboring the
new variant OXA-438 was resistant to penicillins and susceptible
to oxyimino-cephalosporins and showed low-level resistance to
carbapenems (Table 1). In contrast, the other local variants,
KPN163 (OXA-163) and KPN247 (OXA-247), were resistant
to oxyimino-cephalosporins (KPN247 reduced susceptibility to
cefotaxime) and exhibited higher MIC values to ertapenem
(Table 1).
Plasmid Characterization and Genetic Environment.
The blaOXA‑438 gene was successfully transferred by biparental
conjugation, demonstrating the mobilization capacity of the
blaOXA‑438-harboring plasmid, like the previously characterized
blaOXA‑163 and blaOXA‑247 genes.
14
Susceptibility results of ECO438 transconjugant (TC438)
were compared with those of the acceptor strain E. coli J53.
TC438 was resistant to penicillins and susceptible to oxyimino-
cephalosporins but was ≥3 times 2-fold dilutions higher
compared with the acceptor strain E. coli J53. Carbapenem
MICs of TC438 were interpreted as susceptible; however,
ertapenem was ≥3 times 2-fold dilutions higher compared with
the acceptor strain E. coli J53. Overall, the phenotypic
characteristics of TC438 suggest the occurrence of transference
of the blaOXA‑438 plasmid. Susceptibility results of TC163 and
TC247 suggested the transference of blaOXA
14 (Table 1). Briefly,
TC163 and TC247 showed resistance to penicillins, variable
MICs to oxyimino-cephalosporins, and susceptibility to
carbapenems, but ertapenem showed ≥3 times 2-fold dilutions
compared with the acceptor strain E. coli J53.
S1 nuclease showed that ECO438 harbored at least 5
plasmids, and three of them were transferred to TC438 (Figure
S1). PCR of TC438 confirmed the presence of blaOXA‑438 only.
OXA-163 and OXA-247 harbored a ca. 70 kb plasmid, as
previously reported.14 KPN163, KPN247, ECO438, and
corresponding TCs shared a ca. 70 kb plasmid (Figure S1).
Additionally, the clinical isolates KPN163, KPN247, and
ECO438 as well as the transconjugants were confirmed to
carry an IncN2 plasmid.
An analysis of the blaOXA‑438 genetic environment revealed
that this gene was inserted into a structure identical to that found
in blaOXA‑163 and blaOXA‑247.
10,14 Briefly, blaOXA‑438 was bracketed
upstream by the insertion sequence IS4321 and downstream by
a truncated IS4-like element (Figure S2). Altogether, these
results suggest that these enzymes might be carried on highly
similar plasmids.
OXA-48 Variants Harbor Amino Acid Modifications at
the KTG-Associated Loop. The new variants OXA-247 and
OXA-438 were derived fromOXA-48 by mutations occurring in
the vicinity of the conserved motif KTG, specifically in the
region spanning the β5−β6 loop, as observed in Figure 1 and
previously reported.10,13 Also, the alignment shows that the
organization of the active site of OXA-438 seems to be
conserved compared to other OXA-48-derived enzymes,
including the conserved motifs SerThrPheLys (70−73),
TyrGlyAsn (144−146), and LysThrGly (216−218). OXA-163
differs from OXA-48 by the presence of a single amino acid
modification Ser220Asp and the deletion of Arg222−Ile223−
Glu224−Pro225.10 OXA-247 contains the same 4-residue
deletion as OXA-163 and two substitutions Tyr219Ser and
Ser220Asn compared to OXA-48.14 Finally, OXA-438 exhibited
these same modifications and the insertion of two residues
between Tyr219−Asp220, according to the alignment. These
mutations are likely to result in modifications in the folding of
the β5−β6 loop, leading to a local impact on the enzyme
structure. Crystal structures will allow us to better evaluate
which is the actual role of β5−β6 mutations and the
tridimensional arrangement of the residues involved.
Effect of Sodium Bicarbonate on the β-Lactamase
Activity. Upon the first report of the presence of an N-
carboxylated lysine residue in OXA-10,16 Golemi et al.
demonstrated that this residue has a critical role in the reaction
mechanism of OXA-10, participating in a base in the active site
of the enzyme.17 In this paper, the presence of sodium
Figure 2. Effect of sodium bicarbonate on theOXA activity. The initial rates of hydrolysis of nitrocefin were determined under different concentrations
of sodium bicarbonate.
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bicarbonate in the reaction mix was utilized to provide the
necessary amount of CO2 to yieldN-carboxylation of Lys73. To
evaluate the effect of sodium bicarbonate on the activity of OXA-
48 variants, we determined the hydrolysis rate of nitrocefin in
the presence of increasing concentrations of the salt. The general
behavior of all four variants of OXA-48 reflects that, upon
increasing concentrations of CO2, the enzyme shows a stronger
hydrolysis rate over nitrocefin (Figure 2). Overall, the maximum
activity was achieved with 50 mM sodium bicarbonate, which is
probably a saturating concentration; higher concentrations up to
100 mM NaHCO3 were generally detrimental in the hydrolysis
rate, except for OXA-163, which showed a 1.2-fold increase in
the activity. Consequently, in this study, we performed kinetic
reactions using 50 mMNaHCO3 in the reaction buffer, which is
coincidental with that used in previous studies.2,17
Only OXA-48 and OXA-438 showed activity in absence of
sodium bicarbonate, with the hydrolysis rate 4.5- and 7-fold
lower than the activity obtained with 50 mM NaHCO3,
respectively. Interestingly, OXA-163 was less active than the
other variants in the 0.625−25 mM NaHCO3 range, which
suggests that the activity in this variant could be more sensitive
to minor changes in CO2 concentrations within the active site,
and it is evident that, from 50 mM bicarbonate, the activity
resumes as in the rest of the OXA variants.
Comparative Kinetic Behavior of OXA-438 with OXA-
48-Type Enzymes and Redefinition of the Carbapene-
mase Activity. Steady-state kinetic parameters were deter-
mined in the presence of 50 mM sodium bicarbonate (Table 2).
The kinetic behavior of all four OXA β-lactamases was similar
for nitrocefin, showing both high turnover (kcat) and catalytic
efficiency (kcat/Km) values. The four OXA variants showed
different behaviors toward the oxyimino-cephalosporins cefo-
taxime and ceftazidime. For cefotaxime, Km values showed that
OXA-163 can have the highest affinity for Michaelis complex
formation, compared to the high Km values in OXA-247 and
OXA-48. However, compared to OXA-48, OXA-163 showed a
slight improvement in the ability to hydrolyze cefotaxime, albeit
both the kcat and kcat/Km values are almost insignificant to be
considered as biologically relevant; the impossibility to
accurately determine the kcat and kcat/Km values for the other
variants (kcat values were assessed as <0.001 s
−1) relies on the
fact that the high molar extinction coefficient for cefotaxime
Table 2. Steady-State Kinetic Parameters of OXA-48 Variants in the Presence of 50 mM Sodium Bicarbonatea
enzyme parameter nitrocefin cefotaxime ceftazidime imipenem meropenem ertapenem
OXA-48 Km (μM) 60 ± 3 174 ± 14 9900 ± 740 2.3 ± 0.07 0.06 ± 0.002 0.2 ± 0.003
kcat (s
−1) 430 ± 8 <0.001 NH 5 ± 0.3 0.12 ± 0.001 0.03 ± 0.002
kcat/Km (μM
−1 s−1) 7.2 ± 0.5 <6 × 10−6 ND 2.0 ± 0.2 1.9 ± 0.1 0.2 ± 0.03
OXA-163 Km (μM) 35 ± 3 19 ± 1 9200 ± 276 0.03 ± 0.001 0.06 ± 0.002 0.06 ± 0.004
kcat (s
−1) 243 ± 8 0.004 NH 0.06 ± 0.003 0.06 ± 0.003 0.01 ± 0.001
kcat/Km (μM
−1 s−1) 6.9 ± 0.8 2 × 10−4 ND 1.9 ± 0.1 1.0 ± 0.1 0.2 ± 0.03
OXA-247 Km (μM) 50 ± 6 395 ± 35 >10000 3.4 ± 0.1 0.6 ± 0.02 1.4 ± 0.03
kcat (s
−1) 274 ± 12 <0.001 NH 0.8 ± 0.04 0.18 ± 0.01 0.08 ± 0.004
kcat/Km (μM
−1 s−1) 5.5 ± 0.8 <3 × 10−6 ND 0.2 ± 0.02 0.3 ± 0.04 0.1 ± 0.02
OXA-438 Km (μM) 40 ± 3 68 ± 2 >10000 1.9 ± 0.05 0.07 ± 0.001 0.16 ± 0.007
kcat (s
−1) 332 ± 9 <0.001 NH 8 ± 0.5 0.06 ± 0.003 0.03 ± 0.002
kcat/Km (μM
−1 s−1) 8.3 ± 0.8 2 × 10−5 ND 4.4 ± 0.5 0.9 ± 0.09 0.2 ± 0.03
aND, not determined; NH, no hydrolysis was observed under the used experimental conditions.
Figure 3. UV-circular dichroism (CD) and thermal denaturation spectra. Top: (A) far UV CD and (B) near UV CD spectra for OXA-48 variants.
Bottom: (C) thermally induced unfolding transitions were monitored by the evolution of the molar ellipticity at 222 nm and (D) values of the dynode
voltage at each condition.
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(above 25000 M−1 cm−1 at 260 nm) yields absorbance values
that are beyond the detection capacity of the spectrophotometer
whenVmax values were assayed. On the other hand, theKm values
obtained for ceftazidime in all four variants (close to 10mM) are
negligible in terms of biological significance, for which this
antibiotic is not a substrate for OXA-48-related β-lactamases;
this is supported by a nondetectable hydrolytic activity against
ceftazidime upon direct incubation of the enzymes with the
drug.
The Km values obtained for the tested carbapenems
(imipenem, meropenem, and ertapenem) were very low for all
OXA enzymes (Table 2), which can be associated with a very
high affinity. Both OXA-438 and OXA-48 showed the highest
turnover (kcat) for imipenem compared with the other enzymes.
The catalytic efficiency values (kcat/Km) for imipenem were
highest for OXA-438, followed by OXA-48 and OXA-163.
Instead, for Meropenem, OXA-48 showed the highest kcat/Km
values. Ertapenem was the most stable carbapenem against
hydrolysis in all OXA-variants tested (kcat/Km < 1 M
−1 s−1).
Finally, OXA-247 had the weakest carbapenemase hydrolytic
activity (kcat/Km < 1M
−1 s−1). In summary, OXA-438 and OXA-
48 demonstrated the strongest imipenem- and Meropenem-
hydrolyzing activity.
Deletions at the β5−β6 Loop Seem to Impact the
Structural Stability of OXA-48 Variants. A biophysical
characterization was carried out to evaluate the impact on amino
acid substitutions, insertions, and deletions in eachOXA variant.
Even though slight differences were observed, far UV circular
dichroism (CD) spectra (Figure 3 A and B) indicated preserved
secondary structure content for all OXA variants (panel A).
Accordingly, near UV-CD showed some modifications in the
tertiary structure of the variants (panel B). The observed
differences in the content of the tertiary structure could be
attributed at least in part to the deletions in OXA-163, OXA-
247, and OXA-438 compared to OXA-48; however, OXA-247
seems to be the variant with a different behavior that could be
explained by the spatial rearrangements of the polypeptide chain
due to modifications in the amino acid sequence.
To understand if the observed changes lead to alterations in
the global stability, the thermal denaturation profile was
obtained (Figure 3 C and D). For each protein, the evolution
of the elipticity at 222 nm (minima observed in the spectra
shown in Figure 3C) was measured as a function of temperature
while the evolution of the dynode voltage was recorded
simultaneously (Figure 3D). An increase in the latter value
reveals the appearance of protein aggregates, therefore
indicating that thermal-induced aggregation occurred concom-
itantly with the loss of the secondary structure.18 In such cases,
the temperature at the onset of aggregation (To) was obtained as
an assessment of protein stability.19 The observedTo values were
54 °C (OXA-48), 49 °C (OXA-163), 48 °C (OXA-247), and 47
°C (OXA-438). Interestingly, OXA-48 proved to have the
highest stability, with its To up to 7 °C higher than the other
enzymes. Whether these results are correlated with the activities
observed in the absence of sodium bicarbonate remains to be
determined with further studies.
■ CONCLUSIONS
In this study we characterized a carbapenem resistant clinical
isolate Escherichia coli M17224 (ECO438) obtained from a
pediatric patient suffering from leukemia. ECO438 was negative
for all the prevalent carbapenemases but harbored a novel
variant of blaOXA‑48‑like located in a ca. 70 kb IncN2 plasmid.
Moreover, in this work we performed biochemical and
molecular studies to understand the role of mutations occurring
at the β5−β6 loop in OXA-247 and OXA-438 on the hydrolytic
behavior of OXA β-lactamases. We propose that alterations in
the architecture and folding of this loop, which is close to the
conserved KTG motif, modify the hydrolytic behavior on OXA-
48-type β-lactamases and have a strong impact on the overall
structural stability. Further experimental structural studies are
being conducted to better determine this hypothesis.
Judging by the susceptibility behavior of OXA-producing
strains and the observed hydrolytic activity of the enzymes,
additional mechanisms such as reduced permeability through
specific porins and/or active effluxmay be involved in the overall
resistance pattern. This is evidenced, for example, with
imipenem, for which there is a 10-fold reduction in the catalytic
efficiency albeit a reduced susceptibility in the producing strains
is achieved. Therefore, the influence of these additional
mechanisms cannot be ruled out and deserves further analysis.
The analysis of the available kinetic data in the literature for
several OXA β-lactamases raises the fact that kinetic experiments
have often been performed without supplementing the reaction
mixture with a CO2 source (i.e., sodium bicarbonate), which is
needed for lysine N-carboxylation. In these conditions (absence
of bicarbonate), partial N-carboxylation of the active-site lysine
during in vitro experiments is usually achieved, leading to
nonconsistent kinetic parameters (and therefore questionable
results) due to the presence of inactive enzymes in the mixture;
this was already suggested by Antunes et al.,2 where several
studies are suggested for reference. We also demonstrated that
the activity of the OXA enzymes (or at least those studied in this
work) is strongly dependent on the bicarbonate concentration,
suggesting that a 50 mM concentration can be used as standard
amount during kinetic analysis. If we consider that the in vivo
concentration of carbon dioxide was reported to be around 1.3
mM,20 it is expected that the OXA β-lactamases will be fully
carbamylated in bacteria, and the discrepancies that might be
observed between the in vitro analysis and the in vivo behavior
will be strongly dependent on the experimental conditions used,
i.e., the presence or absence of a carbon dioxide source.
■ METHODS
Bacterial Strains. Clinical isolates suspicious of OXA-48-
like production were referred to the National Reference
Laboratory in Antimicrobial Resistance (NRLAR) for further
characterization due to intermediate or resistance phenotypes to
ertapenem, resistance to piperacillin/tazobactam (Clinical and
Laboratory Standards Institute, CLSI 2018),21 and susceptibility
to imipenem and to third- and fourth-generation cephalosporins
(http://antimicrobianos.com.ar/ATB/wp-content/uploads/
2014/10/ALGORITMOS-MAX-Y-MINIMO.pdf).
The isolates used in this study were: E. coli M15260
(ECO48), an OXA-48-producing isolate kindly provided by
Dr. Roberto Melano (Public Health Ontario, Canada);
previously characterized K. pneumoniae M11969 (KPN163),
an OXA-163 producer; K. pneumoniae M13056 (KPN247), an
OXA-247 producer;14 and E. coli M17224 (ECO438), the new
variant OXA-438 producer. E. coli DH5α and E. coli TOP10
were used to clone blaOXA‑type genes. Sodium azide resistant E.
coli J53 was used as the recipient strain in conjugation assays; E.
coli BL21(DE3) (Novagen, USA) was used to induce the
expression of blaOXA‑48‑like genes.
Identification, Antimicrobial Susceptibility Assays,
and PCR Detection of Relevant Genes. The isolates were
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identified using matrix-assisted laser desorption ionization time-
of-flight (MALDI-TOF) mass spectrometry (Bruker, Ger-
many). Carbapenemase activity was screened with the Triton-
Hodge,22 Blue-Carba, and Carba-NP-Direct tests. Extended
spectrum β-lactamases (ESBLs) screening was carried out using
double disk synergy tests following CLSI recommendations.21
The production of OXA-163-type enzymes was suspected using
the immunochromatographic lateral flow assay and the OXA-
163/48 Duo K-SeT test (Coris BioConcept).15 Susceptibility
testing was performed by broth microdilution (Microscan
Walkaway, Beckman Coulter, Inc.) following CLSI guidelines
and interpretation criteria (M100-S28, 2018)21 to ampicillin,
cefotaxime, cephalothin, ceftazidime, ceftazidime-avibactam,
ertapenem, imipenem, and meropenem.
Biparental Conjugation and Plasmid Profile. Biparental
conjugation was performed using a donor and recipient mix ratio
of 1:3 and incubated overnight at 35 °C. Transconjugant cells
were selected on LB agar plates containing ampicillin (50 μg/
mL) plus sodium azide (200 μg/mL).23 Plasmid content and
their estimated sizes were determined by S1-nuclease digestion
of genomic DNA followed by pulsed field gel electrophoresis
(S1-PFGE).24 Incompatibility groups were studied by PCR-
based replicon typing (PBRT),25,26 and specific PCR for IncN2
(see Table S1).
blaOXA48‑ like Alleles and Genetic Environment.
blaOXA‑48‑like alleles were determined by PCR and Sanger
sequencing with specific primers listed in Table S1. The genetic
environment of blaOXA‑48‑like was studied by inverse PCR, as
previously described.10 Briefly, the total plasmid content was
extracted from transconjugant cells with NucleoBond Xtra Midi
(Macherey Nagel, Bethlehem, PA, USA) following the
manufacturer’s protocol. DNA restriction was done withHindIII
and PstI [New England Biolabs (NEB), Ipswich, MA, USA].
After restriction, the plasmid DNA was precipitated with LiCl
and ligated with T4 DNA Ligase (NEB, Ipswich, MA, USA).
pACyC and lambda phage DNA were used as controls. Ligated
DNA was subjected to inverse PCR using outgoing primers
detailed in Table S1. PCR products were run in a 1% agarose gel,
and suspected bands were cut; the DNAwas purified with a PCR
cleanup gel extraction kit (Macherey Nagel, Bethlehem, PA,
USA) and sequenced in an ABI 3500 genetic analyzer (Applied
Biosystems, Foster City, CA, USA). The sequence analysis was
performed using the BLAST program available at the National
Center for Biotechnology Information Web site (http://www.
ncbi.nim.nih.gov/). Multiple-sequence alignments were per-
formed with Clustal Omega (http://www.ebi.ac.uk/Tools/
msa/clustalo/) and BioEdit version 7.0.0. The insertion
sequences were searched in the IS finder (https://www-is.
biotoul.fr/blast.php.
Cloning and Expression of the blaOXA‑48‑like Genes.
blaOXA48‑like cloning was done using a CloneJet PCR cloning kit
(Thermo Fisher Scientific). blaOXA‑48, blaOXA‑163, blaOXA‑247, and
blaOXA‑438 were amplified by conventional PCRwith primers that
introduced restriction enzyme sites (NdeI and HindIII, see
Table S1). Amplification fragments (ca. 780 bp) were cloned
into pJET1.2/blunt vector (Thermo Scientific, Waltham, MA,
USA) following the blunt-end cloning protocol and ligated with
T4 DNA ligase. Prior to electroporation, DNA vectors were
purified with an AccuPrep PCR Purification Kit (Bioneer,
Oakland, CA). Escherichia coli DH5α cells were electroporated
with the ligation product or control vectors in a Gene Pulser II
electroporation system (BioRad, Hercules, CA, USA). Trans-
formed cells were incubated for 1 h at 37 °C and plated onto
1.5% lysogeny broth (LB) agar with 50 μg/mL kanamycin and
1.6 ng/mL X-gal. The recombinant plasmids, pJET1.2/blunt-
OXA (−48, −163, −247, and −438), were purified with an
ADN Puriprep-P kit (Highway, Argentina). Plasmids were
digested with NdeI and HindIII, and the released fragments
corresponding to the blaOXA genes were introduced into NdeI/
HindIII digested expression vector pET28a (Novagen, USA),
rendering the pET28a/OXAs recombinant plasmids. The
identity of the insets was verified by DNA Sanger sequencing.
The plasmid constructions were maintained in E. coli TOP10
cells and transformed into E. coli BL21(DE3) cells for protein
expression.
Production and Purification of OXA β-Lactamases.
Overnight cultures of recombinant E. coli BL21(DE3)
producing OXA β-lactamases were diluted (1/50) in 100 mL
of fresh LB containing 30 μg/mL kanamycin and cultured at 37
°C until reaching an optical density (OD) of 0.7 at 600 nm.
Expression of the β-lactamases genes was carried out at 37 °C for
3 h upon the addition of 0.5 mM isopropyl-β-D-thiogalactopyr-
anoside (IPTG) as an inducer. Bacterial cells were then
harvested by centrifugation (30 min at 10000 rpm, 4 °C),
resuspended in 10 mL of 25 mM sodium phosphate buffer (pH
7.5), and disrupted by sonication. Debris was eliminated by
centrifugation at 13000 rpm for 30 min at 4 °C. Clear
supernatants were filtrated through 0.45 μm pore size
membranes and then loaded onto HisTrap FF affinity columns
(GE Healthcare, USA), previously equilibrated with buffer A
(25 mM sodium phosphate buffer, 10 mM imidazole, pH 7.5).
The β-lactamase activity was determined qualitatively using
nitrocefin hydrolysis. The β-lactamase-containing fractions were
eluted with buffer B (25 mM sodium phosphate buffer, 500 mM
imidazole, pH 7.5) in a two-step gradient (0−50% and 50−
100%). Finally, fractions containing the highest β-lactamase
activities were pooled and subsequently dialyzed overnight
against 25 mM sodium phosphate buffer (pH 7.5). The His-tag
was cleaved by incubating the proteins in the presence of 10 U/
mg thrombin (GEHealthcare, USA) at room temperature for 12
h (overnight). Protein purity was estimated by SDS−PAGE in
12% polyacrylamide gels. The fractions of the purified enzymes
were stored at −80 °C. All chromatography steps were
performed in an ÄKTA Prime Plus purifier (GE Healthcare,
USA). The concentration of all protein samples was determined
by measuring the absorbance at 280 nm.
Influence of Sodium Bicarbonate in the Activity of
OXA Variants. To evaluate the effect of sodium bicarbonate
(NaHCO3) in the activity of the OXA β-lactamases, a
nanomolar concentration of each variant was mixed with
different concentrations of bicarbonate (0 to 100 mM), and the
enzyme reaction was launched upon the addition of 100 μM
nitrocefin. Velocity rates were recorded for 300 s at room
temperature, and initial velocities (v0) were compared for each
NaHCO3 concentration.
Determination of the Steady-State Kinetic Parame-
ters. All the kinetic measurements were performed at 25 °C in
25 mM sodium phosphate buffer (pH 7.5), with or without 50
mM NaHCO3, using a T80 UV−vis spectrophotometer (PG
Instruments Ltd., UK). The steady-state kinetic parameters,
Vmax and Km, were obtained under an initial rate, as described
previously,27 with nonlinear least-squares fitting of the data
(Henri Michaelis−Menten equation; eq 1) performed with
GraphPad Prism 5.03 for Windows (GraphPad Software, Inc.,
La Jolla, CA):
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For low Km values, the kcat values were derived by evaluation of
the complete hydrolysis time courses as described by De
Meester et al.28 For competitive inhibitors, or poor substrates,
the inhibition constant Ki was determined by monitoring the
residual activity of the enzyme in the presence of various
concentrations of the drug and 100 μMnitrocefin as the reporter
substrate;29 the corrected Ki (considered as the observed or








where Km(S) and [S] are the reporter substrate’s Km and fixed
concentration used, respectively.
The following extinction coefficients and wavelengths were
used: nitrocefin (Δε482 = +15000 M−1 cm−1), ceftazidime
(Δε260 = −9000 M−1 cm−1), cefotaxime (Δε260 = −7500 M−1
cm−1), imipenem (Δε300 = −9000 M−1 cm−1), meropenem
(Δε300 = −6500 M−1 cm−1), and ertapenem (Δε300 = −12000
M−1 cm−1).
Circular Dichroism. Spectra were recorded on a Jasco J-810
spectropolarimeter. Data in the near UV (250−320 nm) or in
the far UV (200−250 nm) regions were collected at 25 °C using
10 or 1mm path length cuvettes, respectively. A scan speed of 20
nm/min with a time constant of 1 s was used for all proteins.
Each spectrum was measured at least three times, and the data
were averaged to minimize the noise. The molar ellipticity was
calculated as described elsewhere,30 using mean residue weight
values of 115.18, 115.15, 114.84, and 115.11 for OXA-48, OXA-
163, OXA-247, and OXA-438, respectively.
Thermal Denaturation. Thermal unfolding was monitored
by the change of the dichroic signal at 222 nm. The dynode
voltage (voltage applied to the photomultiplier tube to
compensate for the reduction in the light intensity) was
recorded simultaneously. Each protein sample (200 μL, 3
μM) contained in a 1 mm cell cuvette was gradually heated from
25 to 85 °C at a scan rate of 1 °C/min.
For the spectroscopic techniques, phosphate-buffered saline




The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00537.
List of primers used (Table S1), PFGE photo showing the
number and size of plasmids harbored by the OXA-
producing clinical isolates and transconjugant E. coli
strains (Figure S1), and schematic view of the plasmid-
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Bacteriologiá y Virologiá Molecular (IBaViM), Departamento de
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Departamento de Microbiologiá, Inmunologiá, Biotecnologiá y
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